Follow-The-Filings

Security · featured owners

CAI Caris Life Sciences Inc.

Health Care COM Equity as of 2026 Q2 among managers we track

  • 2 Owners
  • Max 0.7%
  • $209M

CAI (Caris Life Sciences Inc.) is held in 2 featured 13F books as of 2026 Q2. Stanley Druckenmiller - Duquesne Family Office is the largest tracked holder by portfolio weight (0.65%). Figures are as-filed 13F, not free float.

Who owns this now

Largest portfolio weights among featured holders · max 0.7% (Stanley Druckenmiller - Duquesne Family Office) · not free-float ownership

  1. Stanley Druckenmiller 0.65%
  2. Philippe Laffont 0.36%

holders

sorted by value · long equity only · current book 2026 Q2 · open a manager for their book

history
Philippe Laffont - Coatue Management 2026 Q2 0.36% Hold 9,819,992 $175M history
Stanley Druckenmiller - Duquesne Family Office 2026 Q2 0.65% Hold 1,894,450 $34M history

2 current · options excluded

SEC filings

Recent issuer filings from EDGAR · 10 shown · open Filing / Doc on SEC.gov

Filed Form Detail Links
8-K 7.01 Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
8-K 5.07 Filing Doc
10-Q Filing Doc
8-K 2.02,9.01 Filing Doc
DEFA14A Filing Doc
8-K 1.01,1.02,2.03 Filing Doc
10-K Filing Doc
8-K 2.02,7.01,9.01 Filing Doc

Insider forms

Form 3 / 4 / 5 from EDGAR · 9 rows shown

Filed Form Detail Links
4 Period Sep 3, 2026 Filing Doc
4 Period Aug 14, 2026 · 8 forms Filing Doc
4 Period May 15, 2026 Filing Doc
4 Period May 29, 2026 · 2 forms Filing Doc
4 Period May 15, 2026 · 5 forms Filing Doc
4 Period May 11, 2026 Filing Doc
4 Period Mar 6, 2026 · 5 forms Filing Doc
4 Period Feb 26, 2026 Filing Doc
4 Period Feb 26, 2026 Filing Doc

Updated about 19 hours ago Source: SEC EDGAR submissions All on EDGAR

financials

US-GAAP annual · as tagged in Form 10-K · fiscal years · values link to the SEC filing

Income statement

Metric FY2025
Revenue $812.03M
Net income -$68.09M
Net margin * -8.4%

Balance sheet

Metric FY2025
Total current assets $997.8M
Total non-current assets * $127.86M
Total assets $1.13B
Total current liabilities $127.14M
Total non-current liabilities * $421.21M
Total equity $577.31M

Cash flow

Metric FY2025
Cash from operations $83.16M
Cash from investing -$16.26M
Cash from financing $664.99M
Net change in cash $732.01M

Source: SEC companyfacts (US-GAAP 10-K) · * = computed (not a single XBRL tag) · fiscal year as labeled by the issuer · not adjusted or audited by Follow-The-Filings

ownership over time

filing count by report period · click a bar for that quarter’s holders